Format
Sort by
Items per page

Send to

Choose Destination

Best matches for (Cannabidiol) OR cannabinoids:

Cannabinoids in treatment-resistant epilepsy: A review. O'Connell BK et al. Epilepsy Behav. (2017)

Pharmacology of cannabinoids in the treatment of epilepsy. Gaston TE et al. Epilepsy Behav. (2017)

Drug-drug interactions as a result of co-administering Δ<sup>9</sup>-THC and CBD with other psychotropic agents. Rong C et al. Expert Opin Drug Saf. (2018)

Search results

Items: 1 to 20 of 17075

1.

Cannabidiol and the Remainder of the Plant Extract Modulate the Effects of Δ9-Tetrahydrocannabinol on Fear Memory Reconsolidation.

Murkar A, Kent P, Cayer C, James J, Durst T, Merali Z.

Front Behav Neurosci. 2019 Aug 1;13:174. doi: 10.3389/fnbeh.2019.00174. eCollection 2019.

PMID:
31417379
2.

[Medical Cannabis-Related Relapse in a Patient with a History of Alcohol Abuse].

Flöther L, Peitek K, Bucher M, Benndorf RA.

Dtsch Med Wochenschr. 2019 Aug;144(16):1135-1137. doi: 10.1055/a-0805-1973. Epub 2019 Aug 15. German.

PMID:
31416105
3.

Cannabidiol (CBD) use in psychiatric disorders: A systematic.

Bonaccorso S, Ricciardi A, Zangani C, Chiappini S, Schifano F.

Neurotoxicology. 2019 Aug 11. pii: S0161-813X(19)30077-4. doi: 10.1016/j.neuro.2019.08.002. [Epub ahead of print] Review.

PMID:
31412258
4.

Solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the qualitative analysis of 61 synthetic cannabinoid metabolites in urine.

Gaunitz F, Kieliba T, Thevis M, Mercer-Chalmers-Bender K.

Drug Test Anal. 2019 Aug 14. doi: 10.1002/dta.2680. [Epub ahead of print]

PMID:
31412168
5.

In vitro determination of the CB1 efficacy of illicit synthetic cannabinoids.

Sachdev S, Vemuri K, Banister SD, Longworth M, Kassiou M, Santiago M, Makriyannis A, Connor M.

Br J Pharmacol. 2019 Aug 14. doi: 10.1111/bph.14829. [Epub ahead of print]

PMID:
31412133
6.

Evidence for public health on novel psychoactive substance use: a mixed-methods study.

Higgins K, O’Neill N, O’Hara L, Jordan JA, McCann M, O’Neill T, Clarke M, O’Neill T, Campbell A.

Southampton (UK): NIHR Journals Library; 2019 Aug.

7.

Heavy Cannabis Use, Dependence and the Brain: A Clinical Perspective.

Kroon E, Kuhns L, Hoch E, Cousijn J.

Addiction. 2019 Aug 13. doi: 10.1111/add.14776. [Epub ahead of print]

PMID:
31408248
8.

Cannabinoids and inflammation: Implications for People Living with HIV.

Costiniuk CT, Jenabian MA.

AIDS. 2019 Aug 12. doi: 10.1097/QAD.0000000000002345. [Epub ahead of print]

PMID:
31408029
9.

[Comparison of sample preparation techniques in chemical-toxicological analysis of urine for the presence of narcotic drugs, psychotropic substances and their metabolites].

Rizvanova LN, Appolonova SA, Savchuk SA, Zhevelik OD.

Sud Med Ekspert. 2019;62(4):42-46. doi: 10.17116/sudmed20196204142. Russian.

PMID:
31407705
10.

Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use?

Krämer M, Madea B, Hess C.

Drug Test Anal. 2019 Aug 12. doi: 10.1002/dta.2682. [Epub ahead of print]

PMID:
31407526
11.

Cannabis Use and Cognition in Adults Prescribed Opioids for Persistent Pain.

Wildes M, Bigand TL, Layton ME, Wilson M.

Pain Manag Nurs. 2019 Aug 9. pii: S1524-9042(19)30101-8. doi: 10.1016/j.pmn.2019.06.014. [Epub ahead of print]

PMID:
31405787
12.

Burden of Persistent Vomiting With Cannabis Use Disorder: Report From 55,549 Hospitalizations in the United States.

Patel RS, Patel J, Jaladi PR, Bhimanadham NN, Imran S, Tankersley WE.

Psychosomatics. 2019 Jul 11. pii: S0033-3182(19)30121-5. doi: 10.1016/j.psym.2019.07.003. [Epub ahead of print]

PMID:
31405569
13.

Urgent need for "EBMM" in pediatric oncology: Evidence based medical marijuana.

Rod Rassekh S.

Pediatr Hematol Oncol. 2019 Aug 12:1-2. doi: 10.1080/08880018.2019.1651805. [Epub ahead of print]

PMID:
31402734
14.

The Acute Activation of the CB1 Receptor in the Hippocampus Decreases Neurotoxicity and Prevents Spatial Memory Impairment in Rats Lesioned with β-Amyloid 25-35.

Patricio-Martínez A, Sánchez-Zavaleta R, Angulo-Cruz I, Gutierrez-Praxedis L, Ramírez E, Martínez-García I, Limón ID.

Neuroscience. 2019 Aug 7. pii: S0306-4522(19)30543-3. doi: 10.1016/j.neuroscience.2019.08.001. [Epub ahead of print]

PMID:
31400487
15.

Fatalities related to new psychoactive substances in Singapore-A case series.

Chan S, Wu J, Lee B.

Forensic Sci Int. 2019 Jul 26:109892. doi: 10.1016/j.forsciint.2019.109892. [Epub ahead of print]

PMID:
31395407
16.

The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study.

Mitelpunkt A, Kramer U, Hausman Kedem M, Zilbershot Fink E, Orbach R, Chernuha V, Fattal-Valevski A, Deutsch L, Heffetz D, Sacks H.

Epilepsy Behav. 2019 Aug 5;98(Pt A):233-237. doi: 10.1016/j.yebeh.2019.07.007. [Epub ahead of print]

17.

Bones and Joints: The Effects of Cannabinoids on the Skeleton.

Ehrenkranz J, Levine MA.

J Clin Endocrinol Metab. 2019 Aug 8. pii: jc.2019-00665. doi: 10.1210/jc.2019-00665. [Epub ahead of print]

PMID:
31393556
18.

Cannabis Inhalation and Voice Disorders: A Systematic Review.

Meehan-Atrash J, Korzun T, Ziegler A.

JAMA Otolaryngol Head Neck Surg. 2019 Aug 8. doi: 10.1001/jamaoto.2019.1986. [Epub ahead of print]

PMID:
31393535
19.

A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed / fasting states.

Itin C, Domb AJ, Hoffman A.

Expert Opin Drug Deliv. 2019 Aug 12:1-5. doi: 10.1080/17425247.2019.1653852. [Epub ahead of print]

PMID:
31393180
20.

Application device for THC:CBD oromucosal spray in the management of resistant spasticity: pre-production testing.

Montero-Escribano P, Vila Silván C.

Expert Rev Med Devices. 2019 Aug 8. doi: 10.1080/17434440.2019.1653182. [Epub ahead of print]

PMID:
31393179

Supplemental Content

Loading ...
Support Center